SCHEMBL2497225

SCHEMBL2497225

COc1ccc(S(=O)(=O)Cl)c(OC(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.49
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
GAA P10253 2/20 0.38
CHRM5 P08912 2/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TP53 P04637 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2502219 0.88 TRPV4 (0.57) TRPV4GAACHRM5ALPL
SCHEMBL74997 0.83 TRPV4 (0.68) TRPV4L3MBTL1CA12CA1CA2
SCHEMBL29482639 0.83 TRPV4 (0.68) TRPV4L3MBTL1CA12CA1CA2
Potassium Ion SCHEMBL2495134 0.83 CA12 (0.42) CNR1CNR2L3MBTL1CA12CA1
SCHEMBL2495137 0.83 CNR1 (0.41) CNR1CNR2L3MBTL1CA12CA1
SCHEMBL2495200 0.81 TRPV4 (0.45) TRPV4CNR1CNR2L3MBTL1KMT2A
SCHEMBL5704864 0.79 TRPV4 (0.62) TRPV4CNR2ALPL
SCHEMBL2494884 0.78 TRPV4 (0.49) TRPV4L3MBTL1CA12CA1CA2
SCHEMBL15220366 0.78 ALPL (0.51) TRPV4L3MBTL1GAAMAPK1KMT2A
SCHEMBL1023819 0.78 ALPL (0.52) TRPV4ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 TRPV4 355/4885CNR1 123/4885CNR2 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.